0001209191-17-012997.txt : 20170221
0001209191-17-012997.hdr.sgml : 20170221
20170221202523
ACCESSION NUMBER: 0001209191-17-012997
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170216
FILED AS OF DATE: 20170221
DATE AS OF CHANGE: 20170221
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMN HEALTHCARE SERVICES INC
CENTRAL INDEX KEY: 0001142750
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HELP SUPPLY SERVICES [7363]
IRS NUMBER: 061500476
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12400 HIGH BLUFF DRIVE
STREET 2: SUITE 100
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: 8668718519
MAIL ADDRESS:
STREET 1: 12400 HIGH BLUFF DRIVE
STREET 2: SUITE 100
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Scott Brian M.
CENTRAL INDEX KEY: 0001510242
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-16753
FILM NUMBER: 17626832
MAIL ADDRESS:
STREET 1: 12400 HIGH BLUFF DRIVE
STREET 2: SUITE 100
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-02-16
0
0001142750
AMN HEALTHCARE SERVICES INC
AMN
0001510242
Scott Brian M.
12400 HIGH BLUFF DRIVE, SUITE 100
SAN DIEGO
CA
92130
0
1
0
0
CFO/CAO
Common Stock
2017-02-16
4
A
0
17145
0.00
A
91293
D
Common Stock
2017-02-16
4
F
0
8946
38.875
D
82347
D
Common Stock
2017-02-16
4
M
0
3058
0.00
A
85405
D
Common Stock
2017-02-16
4
F
0
1595
38.875
D
83810
D
Common Stock
2017-02-16
4
M
0
2296
0.00
A
86106
D
Common Stock
2017-02-16
4
F
0
1198
38.875
D
84908
D
Common Stock
2017-02-16
4
S
0
9192
40.0484
D
75716
D
Common Stock
2017-02-17
4
S
0
8800
40.0105
D
66916
D
Restricted Stock Units
2017-02-16
4
M
0
3058
0.00
D
Common Stock
3058
2969
D
Restricted Stock Units
2017-02-16
4
M
0
2296
0.00
D
Common Stock
2296
4662
D
The acquisition of Common Stock set forth in this row resulted from the vesting of a Performance Restricted Stock Unit ("PRSU") award granted by the Company on January 3, 2014. The ultimate number of PRSUs that could have been earned and vested under this award depended on the Company achieving or exceeding, on a consolidated basis, a certain specified adjusted earnings before interest, taxes, depreciation and amortization, divided by gross revenue and expressed as a percentage ("Adjusted EBITDA Margin") as of December 31, 2016 for the one-year period beginning on January 1, 2016 and ended December 31, 2016. The maximum amount of PRSUs for this award were deemed earned and vested.
Number of shares withheld for tax purposes.
Common Stock acquired on the vesting of Restricted Stock Units ("RSUs").
Common Stock acquired on the vesting of RSUs.
The sale of 9,192 shares of Common Stock reported in this row was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
The price reported in this row represents a weighted average price of $40.0484 per share. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.20, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
The sale of 8,800 shares of Common Stock reported in this row was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
The price reported in this row represents a weighted average price of $40.0105 per share. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.10, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
The RSUs identified in this row were granted pursuant to the AMN Healthcare Equity Plan. Each RSU represents a contingent right to receive one share of Common Stock.
The RSUs identified in this row were granted on January 5, 2015 and vest on the third anniversary of the grant date, provided, however, the RSUs shall vest on an accelerated basis thirteen months after the grant date, in the incremental amount of 33%, should the Company achieve or exceed a certain specified earnings before interest, taxes, depreciation and amortization (EBITDA) target for the 2015 fiscal year and on the second anniversary of the grant date, in the amount of 34%, should the Company achieve or exceed the specified EBITDA target for the 2016 fiscal year.
RSUs do not have an expiration date.
The RSUs identified in this row were granted on January 5, 2016 and vest on the third anniversary of the grant date, provided, however, the RSUs shall vest on an accelerated basis thirteen months after the grant date, in the incremental amount of 33%, should the Company achieve or exceed a certain specified earnings before interest, taxes, depreciation and amortization (EBITDA) target for the 2016 fiscal year and on the second anniversary of the grant date, in the amount of 34%, should the Company achieve or exceed the specified EBITDA target for the 2017 fiscal year.
/s/ Brian M. Scott
2017-02-21